Key research on the prevention, screening and treatment of GI cancers will be the focus of the 2008 Gastrointestinal Cancers Symposium press program. Study authors will discuss notable research in an embargoed presscast (press briefing via live webcast) on January 23 from 1:00 to 2:00 PM (EST).
Featured research includes:
A study on the association between insurance status and the extent of colorectal cancer spread at the time of diagnosis.
A study evaluating whether a blood serum-based marker called colon cancer-specific antigen-2 (CCSA-2) can aid in the detection of colorectal cancer.
A study assessing the benefit of treatment with a monoclonal antibody called panitumumab for colorectal cancer patients based on their tumors’ molecular signatures.
